| [11C]MET | [S-methyl-11C]methionine |
| [18F]FET | O-(2-[18F]fluoroethyl)-L-tyrosine |
| 1TCM | One-tissue compartment model |
| 2TCM | Two-tissue compartment model |
| AIF | Arterial input function |
| BTV | Biological tumor volume |
| CT | Computed tomography |
| CTAC | Computed tomography-based attenuation correction |
| FADS | Factor analysis of dynamic structures |
| FLAIR | Fluid-attenuated inversion recovery |
| FWHM | Full-width at half-maximum |
| HGG | High-grade glioma |
| IDIF | Image-derived input function |
| IPCA | Incremental principal component analysis |
| LGG | Low-grade glioma |
| MRI | Magnetic resonance imaging |
| NMF | Non-negative matrix factorization |
| p.i. | Post-injection |
| PCA | Principal component analysis |
| PET | Positron emission tomography |
| PK | Pharmacokinetic |
| PVE | Partial volume effect |
| ROI | Region of interest |
| SNR | Signal-to-noise ratio |
| SUV | Standardized uptake value |
| TAC | Time-activity curve |
| TBR | Tumor-to-background ratio |
| TOF-OSEM | Time-of-flight ordered subset expectation maximization |
| TTP | Time-to-peak |
| VOI | Volume of interest |
| WHO | World Health Organization |